QGEN vs CRL

Head-to-Head Stock Analysis & Investment Rating

Last Updated: Sep 09, 2026

QGEN

45.7
AI Score
VS
QGEN Wins

CRL

38.3
AI Score

Investment Advisor Scores

QGEN

46score
Recommendation
HOLD

CRL

38score
Recommendation
SELL

AI Analyst Insights

AI insights temporarily unavailable

Detailed Metrics Comparison

Metric QGEN CRL Winner
Revenue 2.09B 4.02B CRL
Net Income 424.88M -144.34M QGEN
Net Margin 20.3% -3.6% QGEN
Operating Income 465.85M 25.16M QGEN
ROE 11.2% -4.6% QGEN
ROA 6.8% -2.0% QGEN
Total Assets 6.28B 7.14B CRL
Cash 839.00M 213.77M QGEN
Current Ratio 3.90 1.29 QGEN

Relative Price Performance (Last 90 Days)

QGEN 1M: -1.2% · 3M: +13.6% CRL 1M: -2.1% · 3M: +48.0%

Current Technical Phase

QGEN

Neutral
Hold

Mixed signals - no dominant trend phase, RSI 48

RSI (14): 48.2 · Price: $42.50

CRL

Markup
Hold / add on dips

Price above SMA50, rising 50-day trend (16.7% over 20 days), RSI 51

RSI (14): 51.1 · Price: $278.26

Fundamentals Snapshot

Metric QGEN CRL
Market Cap
Forward P/E 16.3 21.9
Trailing P/E 21.6
Revenue (TTM)
Revenue Growth 0.0% 0.0%
Gross Margin 0.7% 0.3%
Operating Margin 0.3% 0.2%
EPS 1.95 -4.72
Dividend Yield 0.01%

Frequently Asked Questions

Based on our detailed analysis, QGEN is currently the stronger investment candidate, winning 7 of the key financial metrics based on our comprehensive scoring model.

We analyze revenue and earnings growth rates in the "Growth" section above. Generally, the company with higher year-over-year revenue and EPS growth is fostering better expansion. Check the table above for the specific growth percentages.

Valuation is determined by metrics like the P/E Ratio and PEG Ratio. A lower P/E typically suggests a stock is cheaper relative to its earnings. Refer to the "Valuation" section in our comparison table to see which stock currently trades at a more attractive multiple.